Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pyoderma gangrenosum and related disorders.

J P Callen1

  • 1Department of Medicine, University of Louisville School of Medicine, Kentucky.

The Medical Clinics of North America
|September 1, 1989
PubMed
Summary

Pyoderma gangrenosum (PG) is a rare skin condition often linked to systemic diseases like inflammatory bowel disease. Effective management involves treating underlying conditions and employing local or systemic therapies targeting neutrophil disorders.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anti-C1q antibodies in systemic lupus erythematosus.

Lupus·2014
Same author

Hypertrophic lupus erythematosus complicating long-standing systemic lupus erythematosus.

Lupus·2011
Same author

Drug-induced subacute cutaneous lupus erythematosus.

Lupus·2010
Same author

Dermatology position paper on the revision of the 1982 ACR criteria for systemic lupus erythematosus.

Lupus·2004
Same author

Vancomycin-induced linear IgA bullous disease presenting as toxic epidermal necrolysis.

Clinical and experimental dermatology·2004
Same author

Update on the management of cutaneous lupus erythematosus.

The British journal of dermatology·2004

Area of Science:

  • Dermatology
  • Immunology

Background:

  • Pyoderma gangrenosum (PG) is an uncommon ulcerative skin condition.
  • PG frequently co-occurs with systemic diseases, notably inflammatory bowel disease, arthritis, and hematologic disorders.

Purpose of the Study:

  • To summarize the understanding of pyoderma gangrenosum's characteristics and associations.
  • To outline current therapeutic approaches for PG.

Main Methods:

  • Review of clinical characteristics of pyoderma gangrenosum.
  • Analysis of associated systemic diseases.
  • Evaluation of treatment strategies for PG.

Main Results:

  • PG presents with distinct ulcerative lesions.
  • Common comorbidities include inflammatory bowel disease, arthritis, and hematologic conditions.
  • No specific cure exists, but management is often successful.

Conclusions:

  • Pyoderma gangrenosum requires a multifaceted treatment approach.
  • Addressing associated systemic diseases is crucial for effective PG management.
  • Therapies targeting neutrophil dysfunction can be beneficial.

Related Experiment Videos